Nobel Award Recognizes Groundbreaking Body's Defenses Research

The prestigious award in medical science was awarded for transformative discoveries that clarify how the immune system targets harmful pathogens while sparing the body's own cells.

A trio of renowned scientists—from Japan Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—share this honor.

Their research uncovered specialized "security guards" within the defense system that eliminate rogue defense cells that could harming the organism.

The discoveries are now enabling new therapies for immune disorders and cancer.

The laureates will share a monetary award worth 11m Swedish kronor.

Decisive Discoveries

"The research has been essential for comprehending how the immune system operates and the reason we do not all suffer from serious autoimmune diseases," commented the chair of the award panel.

This trio's research explain a fundamental mystery: How does the immune system protect us from numerous infections while leaving our healthy cells unharmed?

The body's protection system employs immune cells that search for indicators of disease, including pathogens and germs it has not met before.

These defenders utilize detectors—called recognition units—that are produced randomly in countless combinations.

This provides the defense network the capacity to fight a wide array of invaders, but the randomness of the process inevitably creates immune cells that may attack the host.

Security Guards of the Body

Researchers earlier understood that a portion of these problematic defense cells were eliminated in the thymus—the site where immune cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—described as the body's "security guards"—which patrol the body to neutralize other defenders that attack the body's own tissues.

We know that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and RA.

The prize committee stated, "These findings have laid the foundation for a novel area of investigation and spurred the development of innovative treatments, for example for cancer and autoimmune diseases."

In malignancies, regulatory T-cells block the system from fighting the tumor, so research are focused on reducing their quantity.

For autoimmune diseases, experiments are exploring increasing T-reg cells so the organism is not under attack. A comparable method could also be useful in minimizing the chances of organ transplant rejection.

Innovative Studies

Professor Shimon Sakaguchi, of a Japanese institution, performed experiments on rodents that had their thymus removed, causing autoimmune disease.

The researcher demonstrated that introducing defense cells from other mice could stop the disease—suggesting there was a mechanism for blocking immune cells from harming the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in mice and people that resulted in the discovery of a genetic factor critical for how regulatory T-cells function.

"Their groundbreaking research has uncovered how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly attacking the healthy cells," commented a prominent physiology specialist.

"This research is a remarkable illustration of how fundamental physiological research can have far-reaching consequences for human health."